
AnesdermĀ® 25 mg/g + 25 mg/g Cream + 2 Patches ā 5 g
AnesdermĀ® 25 mg/g + 25 mg/g Cream + 2 Patches ā 5 g
(ŠŠ½ŠµŃŃŠ“ŠµŃŠ¼Ā® ŠŗŃŠµŠ¼ 25 мг/г + 25 мг/г + 2 плаŃŃŃŃŃ, 5 г)
AnesdermĀ® is a topical local anesthetic medicine formulated to provide short-term skin surface anaesthesia (numbing) before minor procedures such as injections, blood draws, laser treatments, or small dermatological interventions. It contains a combination of lidocaine and prilocaine, which are amide-type local anaesthetics that block nerve signal transmission in the skin to reduce pain perception during superficial procedures.
Active Ingredients (per 1 g of cream)
⢠Lidocaine ā 25 mg
⢠Prilocaine ā 25 mg
(Combined local anaesthetic effect)
Key Benefits
⢠Provides effective topical numbing (local anaesthesia) of the skin
⢠Reduces pain associated with needle punctures, injections, minor surgery, or laser treatments
⢠Cream + occlusive patch format supports uniform application and enhanced efficacy
⢠Suitable for adults and adolescents (℠12 years) when used as directed
Indications
Used to support temporary superficial skin anaesthesia prior to procedures such as:
⢠Needle punctures (blood draws, cannula insertion)
⢠Vaccinations and injections
⢠Minor dermatological procedures
⢠Laser therapy and minor skin operations
⢠Procedures on sensitive body areas (as advised by clinician)
How to Use (General Guidance)
⢠Apply a thick layer of cream to the intended skin area to be treated.
⢠Cover the cream immediately with an occlusive patch (provided or similar plastic dressing).
⢠Leave in place for at least 60 minutes before the procedure (unless shorter times are medically advised).
⢠The cream should not be applied more than 5 hours before the procedure on non-genital skin.
⢠Only a healthcare professional should apply the cream to sensitive areas such as genital mucosa, or supervise use in infants/children.
Typical dosing examples:
⢠Adults and adolescents (℠12 years): ~2 g of cream under occlusive patch per procedure site, with ~60 min exposure.
⢠Larger areas: ~1 g per 10 cm², with 2ā5 h exposure under occlusion if needed (for deeper anaesthesia).
⢠Genital skin: Shorter exposure times may be used (e.g., 15 min on male genital skin; 60 min on female genital skin) under medical guidance.
Important: Dosing and exposure time vary by indication, age, and treated area; always follow a healthcare professionalās specific instructions or the product leaflet.
Product Details
⢠Form: Topical anaesthetic cream with occlusive patches
⢠Strength: Lidocaine 25 mg + Prilocaine 25 mg per 1 g cream
⢠Net Weight: 5 g (with 2 patches)
⢠Category: Local anaesthetic for superficial skin procedures
Precautions
⢠For topical use only; do not apply to broken or irritated skin, open wounds (unless under professional supervision), or mucous membranes (nose, mouth, ears, eyes).
⢠Hypersensitivity to lidocaine, prilocaine, or other local anaesthetics (amide group) is a contraindication.
⢠Use in infants and young children should be directed by a healthcare professional due to risk of methemoglobinemia (blood pigment alteration).
⢠Avoid accidental contact with eyes or extended contact longer than recommended.
⢠Consult a healthcare professional before use during pregnancy/breastfeeding or with concomitant cardiac/liver conditions.
This product is a topical medicine intended for short-term local anaesthesia before minor procedures and should be used according to directions or professional guidance.
Original: $12.99
-65%$12.99
$4.55AnesdermĀ® 25 mg/g + 25 mg/g Cream + 2 Patches ā 5 g
AnesdermĀ® 25 mg/g + 25 mg/g Cream + 2 Patches ā 5 g
(ŠŠ½ŠµŃŃŠ“ŠµŃŠ¼Ā® ŠŗŃŠµŠ¼ 25 мг/г + 25 мг/г + 2 плаŃŃŃŃŃ, 5 г)
AnesdermĀ® is a topical local anesthetic medicine formulated to provide short-term skin surface anaesthesia (numbing) before minor procedures such as injections, blood draws, laser treatments, or small dermatological interventions. It contains a combination of lidocaine and prilocaine, which are amide-type local anaesthetics that block nerve signal transmission in the skin to reduce pain perception during superficial procedures.
Active Ingredients (per 1 g of cream)
⢠Lidocaine ā 25 mg
⢠Prilocaine ā 25 mg
(Combined local anaesthetic effect)
Key Benefits
⢠Provides effective topical numbing (local anaesthesia) of the skin
⢠Reduces pain associated with needle punctures, injections, minor surgery, or laser treatments
⢠Cream + occlusive patch format supports uniform application and enhanced efficacy
⢠Suitable for adults and adolescents (℠12 years) when used as directed
Indications
Used to support temporary superficial skin anaesthesia prior to procedures such as:
⢠Needle punctures (blood draws, cannula insertion)
⢠Vaccinations and injections
⢠Minor dermatological procedures
⢠Laser therapy and minor skin operations
⢠Procedures on sensitive body areas (as advised by clinician)
How to Use (General Guidance)
⢠Apply a thick layer of cream to the intended skin area to be treated.
⢠Cover the cream immediately with an occlusive patch (provided or similar plastic dressing).
⢠Leave in place for at least 60 minutes before the procedure (unless shorter times are medically advised).
⢠The cream should not be applied more than 5 hours before the procedure on non-genital skin.
⢠Only a healthcare professional should apply the cream to sensitive areas such as genital mucosa, or supervise use in infants/children.
Typical dosing examples:
⢠Adults and adolescents (℠12 years): ~2 g of cream under occlusive patch per procedure site, with ~60 min exposure.
⢠Larger areas: ~1 g per 10 cm², with 2ā5 h exposure under occlusion if needed (for deeper anaesthesia).
⢠Genital skin: Shorter exposure times may be used (e.g., 15 min on male genital skin; 60 min on female genital skin) under medical guidance.
Important: Dosing and exposure time vary by indication, age, and treated area; always follow a healthcare professionalās specific instructions or the product leaflet.
Product Details
⢠Form: Topical anaesthetic cream with occlusive patches
⢠Strength: Lidocaine 25 mg + Prilocaine 25 mg per 1 g cream
⢠Net Weight: 5 g (with 2 patches)
⢠Category: Local anaesthetic for superficial skin procedures
Precautions
⢠For topical use only; do not apply to broken or irritated skin, open wounds (unless under professional supervision), or mucous membranes (nose, mouth, ears, eyes).
⢠Hypersensitivity to lidocaine, prilocaine, or other local anaesthetics (amide group) is a contraindication.
⢠Use in infants and young children should be directed by a healthcare professional due to risk of methemoglobinemia (blood pigment alteration).
⢠Avoid accidental contact with eyes or extended contact longer than recommended.
⢠Consult a healthcare professional before use during pregnancy/breastfeeding or with concomitant cardiac/liver conditions.
This product is a topical medicine intended for short-term local anaesthesia before minor procedures and should be used according to directions or professional guidance.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
AnesdermĀ® 25 mg/g + 25 mg/g Cream + 2 Patches ā 5 g
(ŠŠ½ŠµŃŃŠ“ŠµŃŠ¼Ā® ŠŗŃŠµŠ¼ 25 мг/г + 25 мг/г + 2 плаŃŃŃŃŃ, 5 г)
AnesdermĀ® is a topical local anesthetic medicine formulated to provide short-term skin surface anaesthesia (numbing) before minor procedures such as injections, blood draws, laser treatments, or small dermatological interventions. It contains a combination of lidocaine and prilocaine, which are amide-type local anaesthetics that block nerve signal transmission in the skin to reduce pain perception during superficial procedures.
Active Ingredients (per 1 g of cream)
⢠Lidocaine ā 25 mg
⢠Prilocaine ā 25 mg
(Combined local anaesthetic effect)
Key Benefits
⢠Provides effective topical numbing (local anaesthesia) of the skin
⢠Reduces pain associated with needle punctures, injections, minor surgery, or laser treatments
⢠Cream + occlusive patch format supports uniform application and enhanced efficacy
⢠Suitable for adults and adolescents (℠12 years) when used as directed
Indications
Used to support temporary superficial skin anaesthesia prior to procedures such as:
⢠Needle punctures (blood draws, cannula insertion)
⢠Vaccinations and injections
⢠Minor dermatological procedures
⢠Laser therapy and minor skin operations
⢠Procedures on sensitive body areas (as advised by clinician)
How to Use (General Guidance)
⢠Apply a thick layer of cream to the intended skin area to be treated.
⢠Cover the cream immediately with an occlusive patch (provided or similar plastic dressing).
⢠Leave in place for at least 60 minutes before the procedure (unless shorter times are medically advised).
⢠The cream should not be applied more than 5 hours before the procedure on non-genital skin.
⢠Only a healthcare professional should apply the cream to sensitive areas such as genital mucosa, or supervise use in infants/children.
Typical dosing examples:
⢠Adults and adolescents (℠12 years): ~2 g of cream under occlusive patch per procedure site, with ~60 min exposure.
⢠Larger areas: ~1 g per 10 cm², with 2ā5 h exposure under occlusion if needed (for deeper anaesthesia).
⢠Genital skin: Shorter exposure times may be used (e.g., 15 min on male genital skin; 60 min on female genital skin) under medical guidance.
Important: Dosing and exposure time vary by indication, age, and treated area; always follow a healthcare professionalās specific instructions or the product leaflet.
Product Details
⢠Form: Topical anaesthetic cream with occlusive patches
⢠Strength: Lidocaine 25 mg + Prilocaine 25 mg per 1 g cream
⢠Net Weight: 5 g (with 2 patches)
⢠Category: Local anaesthetic for superficial skin procedures
Precautions
⢠For topical use only; do not apply to broken or irritated skin, open wounds (unless under professional supervision), or mucous membranes (nose, mouth, ears, eyes).
⢠Hypersensitivity to lidocaine, prilocaine, or other local anaesthetics (amide group) is a contraindication.
⢠Use in infants and young children should be directed by a healthcare professional due to risk of methemoglobinemia (blood pigment alteration).
⢠Avoid accidental contact with eyes or extended contact longer than recommended.
⢠Consult a healthcare professional before use during pregnancy/breastfeeding or with concomitant cardiac/liver conditions.
This product is a topical medicine intended for short-term local anaesthesia before minor procedures and should be used according to directions or professional guidance.















